Merit Pharmaceutical shall not be liable for any damageswhether direct, indirect, incidental, consequential, special, or otherwisearising out of or in connection with the use of, or reliance on, any information provided on this website.
Clinical trials of AOD-9604 lasting up to 24 weeks demonstrated no cardiovascular adverse events and excellent overall tolerability
The three compounds intersect at cellular energy metabolism: NAD+ as a core coenzyme, MOTS-c as a mitochondrial signaling peptide, and 5-Amino-1MQ as an enzyme inhibitor affecting NAD+ availability
It doesn't disrupt the balance of cells or tissues the way a non-salt solution can
Yes, insurance doesnt cover it because it works